How does the flu surge affect CVS revenue mix?

Elevated cases can boost vaccinations, antivirals, rapid tests, and MinuteClinic visits. That typically lifts pharmacy scripts and front-store health categories. For CVS stock today, the key is duration. Sustained January activity could support same-store sales, while shorter peaks may compress the upside window and shift focus back to core utilization trends.

Is CVS technically bullish right now?

Signals are constructive, not emphatic. RSI at 56.46, a positive MACD histogram, and price near the Bollinger upper band support modest upside. ADX at 12.45 shows no strong trend. For CVS stock today, a move above $81 on rising OBV strengthens the case. A drop under $78.60 would weaken momentum and favor consolidation.

What are the main risks to the flu-driven story?

Messaging shifts in federal vaccine policy can alter uptake and payer coverage. Supply or staffing bottlenecks could cap throughput. For CVS stock today, margin pressure from overtime labor, reimbursement dynamics, and any antiviral shortages are watch points. Rapid flu normalization would also reduce incremental scripts and clinic traffic sooner than expected.

How do analysts view CVS into earnings?

Analysts list 22 Buys and 1 Hold with a $92 median target and $90.48 consensus. Forecast paths imply ~$86 near term and ~$91 over a quarter. For CVS stock today, upside depends on flu-driven comps, pharmacy margins, and clinic utilization. Clear guidance on demand trends and costs could be a key re-rating catalyst.

Law and Government

CVS Stock Today: January 02 — ‘Super Flu’ Surge Puts Shots, Scripts in Focus

ByHuzaifa Zahoor January 3, 2026January 3, 2026

CVS stock today sits at the center of the U.S. flu surge story. CDC-tracked illnesses have hit 7.5 million, with hospitalizations nearly doubling week over week, and a super flu H3N2 strain spreading. Investors expect higher vaccine and antiviral demand, plus more clinic visits and testing. We review price, technicals, fundamentals, and policy signals that can shape CVS stock today, so retail investors can decide how to position into earnings on February 11, 2026.